FiercePharmaAsia—Takeda’s cell therapy center; Celltrion’s COVID-19 antibody; Dr. Reddy’s Revlimid deal aliu Fri, 09/18/2020 – 04:29

Sanofi, GlaxoSmithKline score EU supply pact for 300M coronavirus shots kblankenship Fri, 09/18/2020 – 08:50

Biogen stands to lose billions in Tecfidera sales next year, analyst says after new court ruling esagonowsky Fri, […]

Face masks have become an important tool in fighting against the COVID-19 pandemic. However, improper use or disposal […]

A new study released by Houston Methodist takes researchers a significant step closer to developing a uniform, universal […]

Politicians are better than doctors or scientists at medical education. Leaders such as Donald Trump, Vladimir Putin, Alexander […]

The 2012 Health and Social Care Act was the largest ever reorganisation of the English NHS.1 It attracted […]

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

Tumour agnostic therapy demonstrates sustained efficacy